Evaluating double voiding to reduce urinary tract infections in kidney transplant recipients
A Randomized Trial of Double Voiding Versus Usual Voiding to Reduce the Incidence of Urinary Tract Infections in Kidney Transplant Recipients
NA · Weill Medical College of Cornell University · NCT05711446
This study is testing if a technique called double voiding can help kidney transplant recipients reduce their risk of urinary tract infections.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 438 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Weill Medical College of Cornell University (other) |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT05711446 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a technique called double voiding in reducing urinary tract infections (UTIs) among kidney transplant recipients. UTIs are a common complication in these patients, often leading to serious health issues such as bloodstream infections and kidney rejection. The study aims to assess whether double voiding, which involves urinating more than once during a single bathroom visit, can help empty the bladder more completely and thus lower the risk of UTIs. Participants will be adult kidney transplant recipients who are regularly followed at a specific transplant clinic.
Who should consider this trial
Good fit: Ideal candidates for this study are adult kidney transplant recipients who are undergoing routine follow-up care.
Not a fit: Patients who have an indwelling catheter after their transplant will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of urinary tract infections in kidney transplant recipients, improving their overall health outcomes.
How similar studies have performed: While the specific approach of double voiding in this context may be novel, previous studies have indicated that improving urinary voiding techniques can help reduce UTI rates in similar populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic. Exclusion Criteria: * Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley)
Where this trial is running
New York, New York
- Weill Cornell Medical College / NY Presbyterian — New York, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Muthukumar Thangamani, M.D. — Weill Medical College of Cornell University
- Study coordinator: Muthukumar Thangamani, M.D.
- Email: mut9002@med.cornell.edu
- Phone: 212-746-9074
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Urinary Tract Infections, Kidney Transplant, Complications